Heidi J. Gray

Also affiliated with University of Washington, University of Washington Medical Center, University of Washington Applied Physics Laboratory, Seattle University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing”.

Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing

npj Precision Oncology(2023)10.1038/s41698-023-00379-8

N/A

0.500DataRank · unranked

27 citations

Payel Chatterjee, Rachele Rosati, Lauren R. Appleyard, Grace J. Durenberger, Robert L. Diaz +14 more

The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.03.018

N/A

0.415DataRank · unranked

10 citations

William P. Tew, Christopher Purdy, S. Dennis, Andrew Menzin, John L. Lovecchio +16 more

Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.05.013

N/A

0.104DataRank · unranked

1 citations

Austin Miller, Judith A. Smith, Stuart M. Lichtman, Michael A. Bookman, Carol Aghajanian +17 more

Uterine Lavage Identifies Cancer Mutations and Increased TP53 Somatic Mutation Burden in Individuals with Ovarian Cancer

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0314

N/A

0DataRank · unranked

11 citations

Brendan Kohrn, Jeanne Fredrickson, Enna Manhardt, Marc R. Radke, Ronit Katz +13 more

Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-0226

N/A

0DataRank · unranked

57 citations

Kirsten B. Burdett, Kouros Owzar, David Tritchler, Alexander B. Sibley, Yingmiao Liu +16 more

Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study

European Journal of Gynaecological Oncology(2023)10.22514/ejgo.2023.002

N/A

0DataRank · unranked

12 citations

Tsung-Chiung Wu, E Barber, Minh Dao, Emese Zsíros, Renata R. Urban +8 more

Characterization of the Early Years of Bevacizumab Use for First-Line Treatment of Ovarian Cancer in the United States

JCO Oncology Practice(2021)10.1200/op.20.00918

N/A

0DataRank · unranked

2 citations

Barbara A. Goff, Heidi J. Gray, Daniel A. Enquobahrie, Kemi M. Doll, Soledad Jorge